Table 2.
Metabolic variables assessed in blood samples of the study participants before and after the 12-week health training.
| Measurements | Baseline | After 12 weeks | Δ | p |
|---|---|---|---|---|
| TOC (μmol/l) | 0.20 ± 0.04 | 0.13 ± 0.02∗ | −0.07 ± 0.02 | <0.001 |
| TAS (μmol/l) | 0.80 ± 0.28 | 1.45 ± 0.31∗ | 0.65 ± 0.21 | <0.01 |
| TOC/TAS (μmol/l) | 0.25 ± 0.11 | 0.09 ± 0,09∗ | −0.16 ± 0.03 | <0.001 |
| 25(OH)D (ng/ml) | 30.2 ± 2.6 | 38.4 ± 3.9 | 8.2 ± 2.4 | 0.18 |
| TC (mmol/ml) | 5.1 ± 0.9 | 4.8 ± 0.6∗ | −0.3 ± 0.09 | <0.01 |
| HDL-C (mmol/ml) | 1.7 ± 0.4 | 1.6 ± 0.4 | −0.1 ± 0.05 | 1.10 |
| LDL-C (mmol/ml) | 2.9 ± 0.6 | 2.6 ± 0.4 | −0.3 ± 0.08 | <0.21 |
| TG (mmol/ml) | 1.3 ± 0.3 | 0.8 ± 0.3∗ | −0.5 ± 0.1 | <0.01 |
| AIP (mmol/l) | −0.1 ± 0.2 | −0.3 ± 0.2 | −0.2 ± 0.04 | 0.21 |
| TG/HDL-C | 0.9 ± 0.5 | 0.6 ± 0.4 | −0.3 ± 0.07 | 0.31 |
| LDL-C/HDL-C | 1.8 ± 0.5 | 1.7 ± 0.6 | −0.1 ± 0.06 | 0.11 |
| TC/HDL-C | 0.9 ± 0.4 | 0.6 ± 0.3∗ | −0.3 ± 0.1 | <0.01 |
| IL-1β (pg/ml) | 2.56 ± 0.3 | 1.17 ± 0.2∗ | −1.39 ± 0.5 | <0.05 |
| IL-6 (pg/ml) | 36.3 ± 5.9 | 45.8 ± 6.5∗ | 9.5 ± 2.5 | <0.05 |
TOC: total oxidative capacity; TAS: total antioxidant status; 25(OH)D: 25-hydroxyvitamin D; TC: total cholesterol; HDL-C: HDL cholesterol; LDL-C: LDL cholesterol; TG: triglycerides; AIP: atherogenic index of plasma; IL-1β: interleukin-1β; IL-6: interleukin-6. ∗p < 0.05.